Stanford researchers have created a CRISPR-based technology to target RNA in neurons, enabling repair processes for genetic diseases. The method addresses key challenges in Cas9 delivery and DNA repair. It reveals unique genome editing rules in neurons, paving the way for targeted therapies.

Researchers detected tiny tumor DNA fragments in blood, potentially enabling more sensitive cancer screening methods in the future.

Illumina introduced an AI tool designed to assist in diagnosing rare diseases, as part of recent biotech advancements reported on September 4, 2025.

The 17th China Bioindustry Convention opened in Wuhan on September 4, 2025, showcasing innovations from global bio-industry players. Highlights included the world's first plant-derived medical innovation among other groundbreaking achievements.

Researchers detected tiny tumor DNA fragments in blood, enabling more sensitive cancer screening. The breakthrough was shared on September 5, 2025. This could lead to earlier diagnoses.